Centro Medico Nacional Siglo XXI Hospital de Especialidades
Mexico City, 06700, Mexico
NCT Number: NCT03126513
Refractory gastroparesis is a disease characterized by a delayed gastric emptying without a mechanical obstruction. Actual treatments have a limited efficacy and gastric per-oral endoscopic myotomy (G-POEM) is a new treatment that has demonstrated initial promising results in these patients. The investigators aims are to evaluate security and efficacy of this endoscopic treatment in participants with refractory gastroparesis.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Mexico City, 06700, Mexico
Gastroparesis is a chronic, condition characterized by a delayed gastric emptying without a mechanical obstruction. This disease is associated with high morbidity and mortality with a prevalence up to 4% of population. Patients with this disease have a reduced quality of life. The principal etiologies include: post-surgical, diabetes, medications and idiopathic. Symptoms include nausea, vomiting, early satiety, bloating and abdominal pain. Diagnosis is based on the combination of symptoms and studies as gastroscopy that shows retained food in the stomach without a gastric outlet obstruction and confirmed with a gastric emptying scintigraphy. Treatments have limited effect in these patients, including medications, botulinum toxin injection, surgical gastric electrical stimulation, laparoscopic pyloroplasty and stent placement. G-POEM is a new technique based on per-oral endoscopic myotomy treatment in achalasia patients, which has been recently proposed for treatment of patients with refractory gastroparesis with good initial results. The investigators aim is to evaluate the safety and efficacy of this new technique in a group of mexican participants with this disease.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After confirmation of refractory gastroparesis, participants will undergo to gastric POEM. Participants will be admitted to hospital 24hrs before procedure and IV antibiotics will be given and then the procedure will be done. Technique consist of 4 steps: First: a submucosa injection of saline solution with methylene blue at 3-4cms from pylorus. Second: a submucosa incision and tunnel creation up to pyloric area. Third: Myotomy of the circular and longitudinal muscular layers of the pylorus and the antrum. Fourth: closure of the mucosal incision with hemoclips. After procedure they will be kept on surveillance and will be followed-up with clinical, endoscopic and scintigraphic studies up to 1 year after procedure.
Other names: Gastric per-oral endoscopic myotomy
Time frame: 1, 6 and 12 months
The investigators will compare the percentage of improvement in scintigraphy before and after procedure
Time frame: up to 30 days after procedure
measured as the presence of complications during or after procedure
Coordinación de Investigación en Salud, Mexico
Other Gov
Safety and Efficacy of Gastric Per Oral Endoscopic Myotomy (G-POEM) in Patients With Refractory Gastroparesis
Acronym: G-POEM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02732821
Diabetic Gastroparesis, Digestive System Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07505927
Delayed Gastric Emptying Following Procedure, Digestive System Diseases
Jinan, Shandong, China
View Trial DetailsNCT06661668
Digestive System Diseases, Gastrointestinal Diseases
Cologne, North Rhine-Westphalia, Germany
View Trial DetailsNCT05980455
Digestive System Diseases, Gastrointestinal Diseases
Louisville, Kentucky, United States
View Trial Details